Study reveals potential cognitive benefits of antidiabetic drugs

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.

Genetic risk for Alzheimer's disease may be modified by higher meat intake

news.medical.net - 19/Mar 18:11

Older people with a genetic risk of Alzheimer's disease did not experience the expected increase in cognitive decline and dementia risk if they...

Diabetes Mellitus Linked to Dementia Risk, With Highest Risk in T1DM

drugs.com - 19/Mar 15:03

THURSDAY, March 19, 2026 -- Diabetes mellitus (DM) is associated with an elevated risk for dementia, with the highest risk for type 1 diabetes...

Diabetes Mellitus Linked to Dementia Risk, With Highest Risk in T1DM

drugs.com - 19/Mar 15:03

THURSDAY, March 19, 2026 -- Diabetes mellitus (DM) is associated with an elevated risk for dementia, with the highest risk for type 1 diabetes...

Metformin Vs Ozempic: Which Diabetes Drug Is Better For Blood Sugar?

wn.com - 28/Mar 12:57

Metformin is usually the first-choice for the treatment of type 2 diabetes. This drug mainly works by lowering glucose production in the liver. It...

Risk for New Cardiovascular Indications for Anticoagulants ID'd in MCI, Dementia

drugs.com - 16/Mar 14:03

MONDAY, March 16, 2026 -- A considerable proportion of adults with mild cognitive impairment (MCI) or dementia develop new cardiovascular indications...